These studies further suggest that DARS2 may promote the glycolysis process of LUAD cells by promoting the expression of SLC2A1, GPI, ALDOA, and PGAM1, thereby promoting the development of tumor cells. This evidence concerns the gene SLC2A1 and neoplasm.